*  Journal of Current Medical Research and Practice
Introduction Malignant lymphoma is a primary neoplasm of lymphoid tissue. It is the third most common cancer in children ... Background Monitoring of minimal residual disease (MRD) has become a frontline clinical practice in the treatment of virtually ... Real-time quantitative polymerase chain reaction detection of minimal residual disease in acute lymphoblastic leukemia: a ... and in its distinction from other primary and metastatic neoplasms. In this study, we examined the expression of MOC-31 (Anti- ...
  http://jcmrp.eg.net/showstats.asp?sabs=y&a=ts
*  NCT02521493 Clinical Trial - National Cancer Institute
Patients with cytopenias and/or bone marrow blasts who do not meet the criteria for the diagnosis of AML (WHO Myeloid Neoplasm ... minimal residual disease [MRD]-negative after one cycle of induction therapy) after elimination of high dose (HD) Ara-C ( ...
  https://www.cancer.gov/about-cancer/treatment/clinical-trials/search/view?cdrid=775118&version=HealthProfessional&protocolsearchid=15851222
*  Most recent papers with the keyword multiple mieloma | Read by QxMD
The presence of a plasma cell neoplasm can be a surprise and sometimes a diagnostic challenge to the head and neck surgeon. ... High-risk cytogenetics and persistent minimal residual disease by multiparameter flow cytometry predict unsustained complete ... In otorhinolaryngologic literature these neoplasms are rarely described and their nosological arrangement is often confused. ... studies for transplant-eligible MM and the GEM2010MAS65 clinical trial for elderly patients with MM who had minimal residual ...
  https://www.readbyqxmd.com/keyword/45781
*  Assessment of minimal residual disease in acute myeloid leukemia. - Radcliffe Department of Medicine
The last 15 years have witnessed significant improvements in technologies to detect minimal residual disease (MRD) in acute ... PURPOSE OF REVIEW: The last 15 years have witnessed significant improvements in technologies to detect minimal residual disease ...
  https://www.rdm.ox.ac.uk/publications/71138
*  Therapy, excluding Transplantation: Clinical Studies, Minimal Residual Disease, Biomarkers, Novel Approaches and New Agents -...
Session 1: Cystic Neoplasms of the Pancreas. *Session 2: Biliary Tract - Extrahepatic Cholangiocarcinoma I ... Saturday, December 3, 2016: 4:00 PM-5:30 PM Clinical Studies, Minimal Residual Disease, and Biomarkers - Presenters: Thierry ...
  https://www.oncoletter.ch/kongressberichte-live-webcasts/id-58th-annual-meeting-of-the-american-society-of-hematology/id-653-myeloma.html
*  Nivolumab in Eliminating Minimal Residual Disease and Preventing Relapse in Patients With Acute Myeloid Leukemia in Remission...
Neoplasm, Residual. Neoplasms by Histologic Type. Neoplasms. Neoplastic Processes. Pathologic Processes. Nivolumab. Antibodies ... Randomized Phase II Study to Assess the Role of Nivolumab as Single Agent to Eliminate Minimal Residual Disease and Maintain ... To monitor AML minimal residual disease (MRD) by Wilms tumor 1 (WT1) polymerase chain reaction (PCR) at enrollment and at ... Patients are permitted to enroll if they have vitiligo, type I diabetes mellitus, residual hypothyroidism due to autoimmune ...
  https://clinicaltrials.gov/ct2/show/study/NCT02275533?view=results
*  Monitoring Minimal Residual Disease in the Myeloproliferative Neoplasms: Current Applications and Emerging Approaches
... Karl ... Karl Haslam and Stephen E. Langabeer, "Monitoring Minimal Residual Disease in the Myeloproliferative Neoplasms: Current ...
  https://www.hindawi.com/journals/bmri/2016/7241591/cta/
*  Azacitidine (AZA) in Minimal Residual Disease (MRD) Chronic Myeloid Leukemia (CML) - Full Text View - ClinicalTrials.gov
Neoplasm, Residual. Neoplasms by Histologic Type. Neoplasms. Myeloproliferative Disorders. Bone Marrow Diseases. Hematologic ... Azacitidine (AZA) in Minimal Residual Disease (MRD) Chronic Myeloid Leukemia (CML). The safety and scientific validity of this ... Minimal residual disease. Philadelphia chromosome (Ph)-. BCR/ABL-positive. Tyrosine kinase inhibitor. TKI. Azacitidine. 5- ... Phase I-II Study of Low-Dose Azacitidine (Vidaza) in Patients With Chronic Myeloid Leukemia Who Have Minimal Residual Disease ...
  https://clinicaltrials.gov/ct2/show/study/NCT01460498?show_desc=Y
*  Cladribine With Simultaneous or Delayed Rituximab to Treat Hairy Cell Leukemia - Full Text View - ClinicalTrials.gov
Neoplasm, Residual. Neoplasms by Histologic Type. Neoplasms. Lymphoproliferative Disorders. Lymphatic Diseases. ... Rate of minimal residual disease (MRD) identified in patients 6months after beginning cladribine for treatment of HCL compared ... Cladribine with Rituximab delayed by at least 6 months after Cladribine if and when minimal residual disease is detected ... Patients in complete remission (CR) to cladribine have minimal residual disease (MRD) by immunohistochemistry of the bone ...
  https://clinicaltrials.gov/ct2/show/study/NCT00923013?show_desc=Y
*  Effects of Different Types of Perioperative Analgesia on Minimal Residual Disease Development After Colon Cancer Surgery - Full...
Colonic Neoplasms. Neoplasm, Residual. Colorectal Neoplasms. Intestinal Neoplasms. Gastrointestinal Neoplasms. Digestive System ... Neoplasms by Site. Neoplasms. Digestive System Diseases. Gastrointestinal Diseases. Colonic Diseases. Intestinal Diseases. ... Effects of Different Types of Perioperative Analgesia on Minimal Residual Disease Development After Colon Cancer Surgery. The ... minimal residual disease. cancer recurrence. epidural. morphine. piritramide. colon. cancer. circulating cancer cells. colon ...
  https://clinicaltrials.gov/ct2/show/NCT02314871?term=piritramid&draw=2&rank=4
*  Maintenance Therapy With Histamine Dihydrochloride and Interleukin-2 in Adult Acute Myeloid Leukemia (AML) Patients With...
Neoplasm, Residual. Neoplasms by Histologic Type. Neoplasms. Neoplastic Processes. Pathologic Processes. Interleukin-2. ... Patients With Measurable Minimal Residual Disease (MRD)- a Non-interventional Study (NIS). The recruitment status of this study ... in adult patients with AML in first complete remission with measurable minimal residual disease (MRD). Patients are eligible ... Patients With Measurable Minimal Residual Disease (MRD)- a Non-interventional Study (NIS). ...
  https://clinicaltrials.gov/show/NCT01770158
*  Cladribine With Simultaneous or Delayed Rituximab to Treat Hairy Cell Leukemia - Full Text View - ClinicalTrials.gov
Neoplasm, Residual. Neoplasms by Histologic Type. Neoplasms. Lymphoproliferative Disorders. Lymphatic Diseases. ... Randomized Trial of Cladribine (CdA) With Simultaneous or Delayed Rituximab to Eliminate Hairy Cell Leukemia Minimal Residual ... Cladribine with Rituximab delayed by at least 6 months after Cladribine if and when minimal residual disease is detected ... Patients in complete remission (CR) to cladribine have minimal residual disease (MRD) by immunohistochemistry of the bone ...
  https://clinicaltrials.gov/ct2/show/NCT00923013?cond=%22Hairy+cell+leukemia%22&rank=5
*  Treatment of Relapsed T-Cell Acute Lymphoblastic Leukemia or T-Lymphoblastic Lymphoma With MabCampath - Full Text View -...
Neoplasm, Residual. Precursor T-Cell Lymphoblastic Leukemia-Lymphoma. Leukemia, T-Cell. Neoplasms by Histologic Type. Neoplasms ... In Arm B, patients with molecular relapse (minimal residual disease) receive a 4 week treatment with MabCampath followed by ... in T-ALL and T-Lymphoblastic Lymphomas With Minimal Residual Disease (MRD), in Refractory Relapse or in Primary Failure. ...
  https://clinicaltrials.gov/ct2/show/NCT00199030
*  RESIDUAL VITREOUS CORTEX AT THE FOVEA DURING VITRECTOMY FOR PRIMARY RHEGMATOGENOUS RETINAL DETACHMENT REPAIR.
To investigate the frequency of residual cortex and the effectiveness of removal of residual cortex in the fovea during ... Neoplasm, Residual. Remnant of a tumor or cancer after primary, potentially curative therapy. (Dr. Daniel Masys, written ... To investigate the frequency of residual cortex and the effectiveness of removal of residual cortex in the fovea during ... INSPIRATORY CAPACITY plus FUNCTIONAL RESIDUAL CAPACITY; TIDAL VOLUME plus INSPIRATORY RESERVE VOLUME plus functional residual ...
  https://www.bioportfolio.com/resources/pmarticle/1770841/Residual-Vitreous-Cortex-At-The-Fovea-During-Vitrectomy-For-Primary-Rhegmatogenous-Retinal.html
*  Estimation of the individual residual risk of cervical cancer after vaccination with the nonavalent HPV vaccine.
Neoplasm, Residual. Remnant of a tumor or cancer after primary, potentially curative therapy. (Dr. Daniel Masys, written ... Summary of "Estimation of the individual residual risk of cervical cancer after vaccination with the nonavalent HPV vaccine.". ... Estimation of the individual residual risk of cervical cancer after vaccination with the nonavalent HPV vaccine.. 08:00 EDT ... Home » Topics » Women's Health » Research » Estimation of the individual residual risk of cervical cancer after vaccination ...
  https://www.bioportfolio.com/resources/pmarticle/1995087/Estimation-of-the-individual-residual-risk-of-cervical-cancer-after-vaccination-with.html
*  The treatment of neuroblastoma with intraspinal extension with chemotherapy followed by surgical removal of residual disease. A...
Neoplasm, Residual / surgery. Neuroblastoma / complications, drug therapy*, surgery*. Neurologic Examination. Paraplegia / ... Spinal Neoplasms / complications, drug therapy*, surgery*. Survival Rate. Treatment Outcome. From MEDLINE®/PubMed®, a database ... The treatment of neuroblastoma with intraspinal extension with chemotherapy followed by surgical removal of residual disease. A ...
  http://www.biomedsearch.com/nih/treatment-neuroblastoma-with-intraspinal-extension/8674009.html
*  T-cell Minimal Residual Disease (MRD) Evaluation Using Flow Cytometric Analysis
... minimal residual disease) can be found in the blood (only) as opposed to bone marrow in children with ALL (acute lymphoblastic ... Neoplasm, Residual. .map{width:100%;height:300px;margin-bottom:15px}. Name. Location. ...
  http://www.knowcancer.com/cancer-trials/NCT01078337/
*  Percent reduction of growth hormone levels correlates closely with percent resected tumor volume in acromegaly. - NextBio...
Neoplasm, Residual Pituitary Neoplasms Treatment Outcome Tumor Burden Substances Human Growth Hormone Insulin-Like Growth ... The volume of residual tumor as a fraction of preoperative tumor volume was correlated with GH levels before and after surgery ... had precise measurements of initial and residual tumor, and 3) were not on medical therapy. Densely granulated tumors produced ...
  http://www.nextbio.com/b/search/article.nb?id=25423276
*  Neoadjuvant Chemotherapy With Carboplatin and Docetaxel in Patients With Advanced Ovarian Cancer-Prospective, Randomized Phase...
Neoplasm, Residual. Additional relevant MeSH terms: Neoplasms. Ovarian Neoplasms. Endocrine Gland Neoplasms. Neoplasms by Site ... Genital Neoplasms, Female. Urogenital Neoplasms. Endocrine System Diseases. Gonadal Disorders. Docetaxel. Carboplatin. ...
  https://clinicaltrials.gov/ct2/show/NCT00551577
*  Survival analysis according to the epidermal growth fac | Open-i
... residual tumor after debulking surgery, lymphovascular space involvement, lymph node metastasis, high cancer antigen 125, ... Neoplasms, Glandular and Epithelial/diagnosis*/pathology/surgery. *Ovarian Neoplasms/diagnosis*/pathology/surgery ... residual tumor after debulking surgery, lymphovascular space involvement, lymph node metastasis, high cancer antigen 125, ...
  https://openi.nlm.nih.gov/detailedresult.php?img=PMC4195305_jgo-25-334-g002&req=4
*  adenosquamous cell carcinoma of cervix uteri 2005:2010[pubdate] *count=100 - BioMedLib™ search engine
Neoplasm, Residual. Retrospective Studies. Survival Analysis. *Genetic Alliance. consumer health - Cervical cancer. ... Neoplasm Invasiveness / pathology. Neoplasm Recurrence, Local / drug therapy. Salvage Therapy. Uterine Cervical Neoplasms / ... Endometrial Neoplasms / virology. Female. Humans. Middle Aged. Ovarian Neoplasms / pathology. Ovarian Neoplasms / virology. ... Uterine Cervical Neoplasms / drug therapy. Uterine Cervical Neoplasms / surgery. *[MeSH-minor] Adult. Aged. Bleomycin / ...
  http://www.bmlsearch.com/?kwr=adenosquamous+cell+carcinoma+of+cervix+uteri+2005:2010%5Bpubdate%5D&cxts=100&stmp=b0
*  adult acute myeloid leukemia cellular diagnosis 2005:2010[pubdate] *count=100 - BioMedLib™ search engine
MeSH-major] Antigens, Neoplasm / genetics. Leukemia, Myeloid, Acute / genetics. Neoplasm, Residual / diagnosis. WT1 Proteins / ... Hematologic Neoplasms / complications. Hematologic Neoplasms / mortality. Hematologic Neoplasms / therapy. Humans. Middle Aged ... Neoplasm, Residual. Peripheral Blood Stem Cell Transplantation. Polymerase Chain Reaction / methods. Prognosis. Randomized ... Neoplasm Proteins / metabolism. *[MeSH-minor] Adolescent. Adult. Aged. Antigens, CD34 / metabolism. Drug Resistance, Neoplasm. ...
  http://www.bmlsearch.com/?kwr=adult+acute+myeloid+leukemia+cellular+diagnosis+2005:2010%5Bpubdate%5D&cxts=100&stmp=b0
*  testicular choriocarcinoma and embryonal carcinoma drug therapy 2000:2010[pubdate] *count=100 - BioMedLib™ search engine
Lung Neoplasms / radiography. Lung Neoplasms / secondary. Lymphatic Metastasis. Male. Neoplasm, Residual. Skin Transplantation ... Lung Neoplasms / drug therapy. Lung Neoplasms / secondary. Male. Neoplasms, Multiple Primary. Treatment Outcome. Vinblastine / ... Neoplasms, Second Primary / diagnosis. Seminoma / diagnosis. Testicular Neoplasms / diagnosis. Testicular Neoplasms / drug ... Neoplasm Staging. Neoplasms, Second Primary / pathology. Neoplasms, Second Primary / therapy. Sarcoma / complications. Sarcoma ...
  http://www.bmlsearch.com/?kwr=testicular+choriocarcinoma+and+embryonal+carcinoma+drug+therapy+2000:2010%5Bpubdate%5D&cxts=100&stmp=b1
*  TEM - ncsgna
Residual neoplasm or uncertain margin after endoscopic resection  Excision of benign rectal stenoses  Palliation of advanced ...
  http://slidegur.com/doc/129067/tem---ncsgna